Unusual Options Activity: SLB, Z and Others Attract Market Bets, SLB V/OI Ratio Reaches 375.0
EST Dec 19th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Least Shorted S&P 500 Stocks in November
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Express News | Abbott : RBC Raises Target Price to $135 From $130
Express News | Abbott's Freestyle Libre® 2 Now Reimbursed for Children and Adults Living With Diabetes in Alberta
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $133
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
Should Weakness in Abbott Laboratories' (NYSE:ABT) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Abbott Laboratories To Go Ex-Dividend On January 15th, 2025 With 0.59 USD Dividend Per Share
December 13th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on January 15th, 2025.Shareholders of record on January 15th, 2025 will receive 0.59 USD dividend per share on
Abbott Labs Extends Royal Dividend Run With 7.3% Increase
Abbott Labs Raises Quarterly Dividend to 59c From 55c >ABT
Express News | Abbott Increases Quarterly Dividend for 53Rd Consecutive Year
Press Release: Abbott Increases Quarterly Dividend for 53rd Consecutive Year
Nephron Adjusts Price Target on Abbott Laboratories to $120 From $118
Market Mania Won't Last. Buy These 8 Stocks to Weather the Storm, Analyst Says.